Ignite Creation Date:
2025-12-24 @ 3:07 PM
Ignite Modification Date:
2026-02-20 @ 6:39 PM
Study NCT ID:
NCT02579759
Status:
COMPLETED
Last Update Posted:
2020-02-27
First Post:
2015-09-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)
Sponsor:
Pharnext S.C.A.
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CLN-PXT3003-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None